Stockscreener 앱 받기
2.40
2.13%
0.05
시장 영업 전:
2.40
Abcellera Biologics Inc 주식(ABCL)의 최신 뉴스
What To Expect From AbCellera Biologics Inc (ABCL) Q4 2024 Earni - GuruFocus.com
Thermopylae holdings acquires $742,242 in AbCellera shares By Investing.com - Investing.com Australia
Thermopylae holdings acquires $742,242 in AbCellera shares - Investing.com India
Major Stakeholder Makes Bold Move with AbCellera Biologics Stock Purchase! - TipRanks
Abcellera stock hits 52-week low at $2.20 amid market challenges - Investing.com Australia
AbCellera biologics director John Montalbano acquires $57,499 in shares By Investing.com - Investing.com South Africa
AbCellera biologics director John Montalbano acquires $57,499 in shares - Investing.com India
Independent Non-Employee Director of AbCellera Biologics Picks Up 66% More Stock - Simply Wall St
Ambarella, Builders Firstsource, Sherwin-Williams, AutoZone, AbCellera: Stock Moves That Shocked the Market - TipRanks
Director Makes Bold Move with Major Stock Purchase in AbCellera Biologics - TipRanks
Abcellera Biologics director Montalbano buys $140,568 in shares By Investing.com - Investing.com South Africa
Abcellera Biologics director Montalbano buys $140,568 in shares - Investing.com
Q1 Earnings Estimate for ABCL Issued By Bloom Burton - Defense World
Sanctuary Advisors LLC Decreases Stake in AbCellera Biologics Inc. (NASDAQ:ABCL) - Defense World
AbCellera Biologics’ (ABCL) Hold Rating Reaffirmed at Benchmark - Defense World
Benchmark maintains Hold on AbCellera stock, no price target change - Investing.com
Benchmark maintains Hold on AbCellera stock, no price target change By Investing.com - Investing.com UK
Stifel Nicolaus Issues Pessimistic Forecast for AbCellera Biologics (NASDAQ:ABCL) Stock Price - MarketBeat
AbCellera Biologics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance UK
AbCellera Biologics (NASDAQ:ABCL) Reaches New 52-Week Low on Analyst Downgrade - MarketBeat
AbCellera Biologics (ABCL) Projected to Post Earnings on Thursday - MarketBeat
AbCellera Biologics (NASDAQ:ABCL) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
AbCellera Biologics (NASDAQ:ABCL) Posts Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
AbCellera Biologics’ Earnings Call: Transition Amid Challenges - TipRanks
Abcellera stock hits 52-week low at $2.33 amid market challenges - Investing.com India
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Misses Revenue Estimates - MSN
AbCellera Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com
AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2024 Earnings Call Transcript - Insider Monkey
AbCellera Biologics Inc (ABCL) Q4 2024 Earnings Call Highlights: Strategic Shifts Amid ... - Yahoo Finance
AbCellera Biologics Reports 2024 Financial Results - TipRanks
Abcellera Biologics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
AbCellera Reports Full Year 2024 Business Results - sharewise
Abcellera Biologics earnings beat by $0.01, revenue fell short of estimates - Investing.com
AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript - MSN
AbCellera Biologics Reports 2024 Financial Results and Growth - TipRanks
AbCellera Biologics Inc. SEC 10-K Report - TradingView
AbCellera Biologics Q4 2024 Earnings Preview - MSN
Earnings Scheduled For February 27, 2025 - Benzinga
What To Expect From AbCellera Biologics Inc (ABCL) Q4 2024 Earnings - Yahoo Finance
AbCellera Biologics (NASDAQ:ABCL) Trading Down 8.5%Here's What Happened - MarketBeat
AbCellera Biologics (NASDAQ:ABCL) Shares Gap UpShould You Buy? - MarketBeat
This Healthcare Stock Rose Sharply On USPTO Issuance - The Globe and Mail
AbCellera reassigns COO to CTO role, dissolves position - Investing.com India
AbCellera Biologics Changes COO's Title to Technology Chief -February 18, 2025 at 12:57 pm EST - Marketscreener.com
AbCellera reassigns COO to CTO role, dissolves position By Investing.com - Investing.com South Africa
One AbCellera Biologics Insider Raised Their Stake In The Previous Year - Yahoo Finance
Abcellera Biologics, other AI health stocks gain as Ellison touts AI's promise - MSN
AbCellera Biologics Inc. (NASDAQ:ABCL) Short Interest Update - MarketBeat
AbCellera Biologics (ABCL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
AbCellera Biologics (ABCL) to Release Earnings on Tuesday - MarketBeat
Moloney Securities Asset Management LLC Takes $265,000 Position in AbCellera Biologics Inc. (NASDAQ:ABCL) - MarketBeat
AbCellera to Participate at Upcoming Investor Conferences in March 2025 - BioSpace
AbCellera Biologics (NASDAQ:ABCL) Shares Down 5%Time to Sell? - MarketBeat
AbCellera to Participate at Upcoming Investor Conferences in March - The Globe and Mail
1.39%
0.55%
자본화:
|
볼륨(24시간):